Neuromuscular Disorders

Featured Article

Differentiating Multiple Sclerosis Mimics on MRI

Differentiating Multiple Sclerosis Mimics on MRI

A proper MS diagnosis can only be made after obtaining imaging from the entire brain and understanding the clinical context.

Latest

Case Report: Treatment With Alemtuzumab May Prompt Severe CNS Disease

Case Report: Treatment With Alemtuzumab May Prompt Severe CNS Disease

Researchers report 2 cases of a severe B-cell-mediated CNS disease after treatment with alemtuzumab in patients with multiple sclerosis.

Alexion Seeking New Indication for Myasthenia Gravis Drug

Alexion Seeking New Indication for Myasthenia Gravis Drug

Soliris is currently approved to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Template Improves Quality of Report on MRI for Multiple Sclerosis

Template Improves Quality of Report on MRI for Multiple Sclerosis

More structured MRI reports may aid in the diagnosis of multiple sclerosis.

Potential Prognostic Biomarker for Clinically Isolated Syndrome

Potential Prognostic Biomarker for Clinically Isolated Syndrome

It is not clear whether CSF CD27 could provide novel or simply complementary prognostic value in clinically isolated syndrome.

FDA Approves First Treatment for Spinal Muscular Atrophy

FDA Approves First Treatment for Spinal Muscular Atrophy

The US FDA has approved the first drug for the treatment of spinal muscular atrophy, a genetic disease that often results in premature death.

ACE Inhibitors May Help Slow Myocardial Fibrosis In Muscular Dystrophy

ACE Inhibitors May Help Slow Myocardial Fibrosis In Muscular Dystrophy

Patients who received ACE inhibitors showed a slower progression of myocardial fibrosis and fewer cardiovascular events.

Low Neonatal Vitamin D May Increase Risk of MS

Low Neonatal Vitamin D May Increase Risk of MS

Low levels of neonatal vitamin D may be linked with risk of developing multiple sclerosis.

New Drug for Spinal Muscular Atrophy Shows Promise

New Drug for Spinal Muscular Atrophy Shows Promise

Despite the benefits observed, the improvements still do not represent normal muscle function.

Surgery May Boost Risk of Guillain-Barré in Immuno-Compromised

Surgery May Boost Risk of Guillain-Barré in Immuno-Compromised

Patients with cancer or an autoimmune disease who underwent surgery were at a greater risk.

Rituximab Offers Hope for Refractory Myasthenia Gravis

Rituximab Offers Hope for Refractory Myasthenia Gravis

Sixty-three percent of patients achieved a complete and stable response that allowed them to discontinue all immunotherapies.

Sign Up for Free e-newsletters